A Phase I/IIa, Open-label, Non-randomized, Study of ASC-101 in Patients With Hematologic Malignancies or Myelodysplastic Syndrome (MDS) Who Are Candidates for Dual-cord Umbilical Cord Blood Transplantation (UCBT)

Trial Profile

A Phase I/IIa, Open-label, Non-randomized, Study of ASC-101 in Patients With Hematologic Malignancies or Myelodysplastic Syndrome (MDS) Who Are Candidates for Dual-cord Umbilical Cord Blood Transplantation (UCBT)

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 19 Mar 2015

At a glance

  • Drugs TZ 101 (Primary)
  • Indications Haematological malignancies; Myelodysplastic syndromes
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Mar 2015 Last checked against ClinicalTrials.gov record.
    • 20 Nov 2013 New source identified and integrated: ClinicalTrials.gov record.
    • 09 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top